Curiously, however, about half of the genes positively regulated by HOXC6 in experimental models are actually downregulated in prostate cancers, including three genes encoding inhibitors of WNT signaling, WIF1, DKK3 and SFRP1 [15]. The gene discussed is HOXC6; the disease is prostate carcinoma.